A Double-blind, Randomised, Placebo and Mesalazine Controlled Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Active Colitis.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Dersalazine (Primary) ; Mesalazine
- Indications Ulcerative colitis
- Focus Adverse reactions
- Sponsors Palau Pharma
- 16 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Nov 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 24 Apr 2010 Planned end date changed from 1 Apr 2010 to 1 May 2010 as reported by ClinicalTrials.gov.